This inventor holds 6 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Illumina Corporation, Illumina Cambridge Limited. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020-2025
Title: The Innovations of Stephen M Gross
Introduction
Stephen M Gross is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, holding a total of 6 patents. His work primarily focuses on methods and compositions that enhance the efficiency of nucleic acid manipulation.
Latest Patents
Among his latest patents is a disclosure titled "Compositions and methods for improving library enrichment." This patent describes a hybridization buffer that includes a crowding agent, along with methods for using this buffer and a kit that incorporates it. Additionally, it outlines blockers for hybrid capture methods and a novel method of hybrid capture that avoids the need for PCR amplification prior to sequencing. Another significant patent is "Tagmentation using immobilized transposomes with linkers," which details methods and compositions for fragmenting and tagging nucleic acids using transposome complexes bound to a solid support.
Career Highlights
Stephen has worked with prominent companies in the biotechnology sector, including Illumina Corporation and Illumina Cambridge Limited. His experience in these organizations has allowed him to contribute to cutting-edge research and development in genetic sequencing technologies.
Collaborations
Throughout his career, Stephen has collaborated with talented individuals such as Grace DeSantis and Jian-Sen Li. These partnerships have further enriched his work and expanded the impact of his innovations.
Conclusion
Stephen M Gross is a distinguished inventor whose work in biotechnology has led to several important patents. His contributions continue to influence the field and enhance our understanding of nucleic acid manipulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile